TFR results and resources
Guidelines and Recommendations on Treatment-Free Remission in CML
First recommendations exist about how to manage to stop and re-start therapy, based on early data from previous studies like the French STIM studies, the largest stop study EUROSKI as well as company-sponsored studies ENESTop, ENESTfreedom and DASFREE. The ELN, NCCN (USA) and ESMO (Europe) have published first recommendations for stopping treatment outside the context of clinical trials and the institutional requirements of the centre and lab. However, there is still no wide consensus among the CML experts, prognostic factors for TFR success are not yet clear, and the emotional impact is not yet well understood by doctors and patients.
Our publication in LEUKEMIA
Our paper “Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs” has been published in the scientific journal Leukemia in 2020.
Our TFR for CML patients’ study shows patient-based evidence on unmet needs of CML patients during the treatment-free remission journey.
Open Access Article in Leukemia: https://www.nature.com/articles/s41375-020-0867-0
Our full slide deck with TFR4CML survey data
Our ESHCML2020 Abstract and Oral Presentation
TFR4CML results presented at the European School of Hematology, 22nd Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy.
Our Abstract “Chronic Myeloid Leukemia Patients’ Concerns during Phase I of the Treatment-Free Remission Journey: Communication Between Patients and Doctors in the Different CML Advocates Network Regions” was accepted to be presented by our co-founder Giora Sharf as part of the scientific session 7: #TreatmentFreeRemission – Predictive factors”.
Read the full Abstract ESHCML 2020 Abstract CMLAdvocatesNetwork
Our IACH2020 Abstract and Poster Presentation
Abstract and Poster presented at the International Academy for Clinical Hematology (IACH) 2020 Congress.
Read the Poster IACH2020 Poster CMLAdvocatesNetwork (1.36 MB)
Our EHA 2020 Abstract and Poster
Our Abstract “CML Patients’ Views on Psychological Support Throughout the Treatment-Free Remission Journey” has been accepted at the 25th Congress of the European Hematology Association starting June 11.
Due to the COVID-19 outbreak, this year #EHA2020 has become a virtual event as have many other congresses, and the EHA Virtual Congress Platform will be accessible until October 15, 2020.
You can check in detail the E-Poster presented in EHA25Virtual by clicking in the image below:
Our ECRD 2020 abstract and poster
We are happy to announce that the European Conference on Rare Diseases and Orphan Products 2020 has selected our abstract and poster “CML Patients’ Views on Psychological Support Throughout the Treatment-Free Remission Journey” to be presented at the conference that will take place online 14-15 May 2020.
Our ASH 2019 Abstract
The 61st American Society of Hematology Congress 2019 had selected our abstract “CML Patients’ Views on Psychological Support throughout the Treatment-Free Remission Journey” published online in the November supplemental issue of the prestigious magazine Blood. To read the full text of the Abstract “CML Patients’ Views on Psychological Support throughout the Treatment-Free Remission Journey”, please click on the image on the right.
Our ASH 2019 Poster
Our Abstract has been additionally selected for Poster presentation as part of the scientific session 632 Chronic Myeloid Leukemia: Therapy: Poster II. Hematology Disease Topics & Pathways: Adult, Diseases, CML, Study Population, Myeloid Malignancies, taking place on Sunday, December 8, 2019, 6:00 PM-8:00 PM at Hall B, Level 2 (Orange County Convention Center), Orlando, USA.
To check and download the #ASH19 Poster “Chronic Myeloid Leukemia Patients’ Views on Psychological Support Throughout the Treatment-Free Remission Journey”, please, click on the image below:
